| Start date | Site | Title | Topic |
---|
ML24200A183 | 21 August 2024 | | Interim Staff Guidance, NMSS-ISG-03, Guidance for Implementation of 10 CFR Part 35 Training and Experience Requirements | Brachytherapy |
ML24031A609 | 31 January 2024 | | FY2023 Nuclear Material Event Database (NMED) Annual Report | Deep Dose Equivalent Pandemic COVID-19 Brachytherapy Stolen Backfit Exit Sign Overexposure Reactive Inspection |
ML24033A303 | 23 January 2024 | | Draft for ACMUI Review - Interim Staff Guidance NMSS-ISG- Guidance for the Implementation of 10 CFR Part 25 Training & Experience Requirements - Draft for Comment | |
ML23284A132 | 27 November 2023 | | OMB-3150-0010 - Final Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material 2023 | Brachytherapy |
ML23320A242 | 16 November 2023 | | Ots Chapter 246-231 Wac Package Transportation (002) | Condition Adverse to Quality Exclusive Use Depleted uranium |
SECY-23-0093, Weekly Information Report Week Ending October 27, 2023 | 1 November 2023 | | SECY-23-0093: Weekly Information Report Week Ending October 27, 2023 | |
ML23257A264 | 29 September 2023 | | Summary of August 29, 2023, Public Meeting on Regulatory Basis for Part 35 Rulemaking on Rb-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material | |
ML23257A263 | 29 August 2023 | | Transcript for the August 29, 2023, Public Meeting on Regulatory Basis for Part 35 Rulemaking on Rb-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material | Enforcement Discretion Brachytherapy |
ML23240A718 | 29 August 2023 | | Slides - Public Meeting on Regulatory Basis for Rb-82 Generators, Emerging Medical Technologies, and Other Medical Use of Byproduct Material | Enforcement Discretion Brachytherapy |
ML23241A914 | 23 August 2023 | | t180-13 Effective 2021-04-05 Highlighted | Incorporated by reference Condition Adverse to Quality Exclusive Use Depleted uranium |
ML23241A917 | 23 August 2023 | | t180-13 Effective 2022-11-02 Highlighted | Incorporated by reference Condition Adverse to Quality Exclusive Use Depleted uranium |
ML23270B389 | 11 August 2023 | | NRC-2021-000227 - Released Set Part 1 | Enforcement Discretion Cyber Security Open House License Renewal Pandemic COVID-19 Brachytherapy Environmental Justice TheraSphere Pre-submittal Pre-application |
ML23198A203 | 20 July 2023 | | Public Meeting on Information Request-Draft Regulatory Guide 8061, July 20, 2023 | |
ML23187A446 | 11 July 2023 | | STC-23-049 Notification of Issuance for Public Comment of the Regulatory Basis for the Rulemaking to Establish Requirements for Rubidium-82 Generators | |
ML23122A356 | 30 June 2023 | | Regulatory Basis: Rulemaking on Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material | Enforcement Discretion Decommissioning Funding Plan Exemption Request Brachytherapy TheraSphere |
ML23167A360 | 14 June 2023 | | Wac Chapter 246-231 Packaging and Transportation of Radioactive Material | Condition Adverse to Quality Exclusive Use Depleted uranium |
ML23186A027 | 8 June 2023 | | Emerging Medical Technologies | Brachytherapy |
ML23137A012 | 5 June 2023 | | OMB-3150-0010 - Draft Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material (2023) | Brachytherapy |
ML23108A247 | 15 May 2023 | | Rulemaking Attachment: Semiannual Status Report on the Licensing Activities and Regulatory Duties of the NRC from October 2022 - March 2023 | Cyber Security |
ENS 56510 | 6 May 2023 15:30:00 | Ihc Health Services, Dba Intermount | Liquid Radioactive Contamination | |
ML23122A118 | 3 May 2023 | | Responses to ACMUI Comments on the Regulatory Basis for the Rulemaking to Establish Requirements for Rb-82 Generators and Emerging Medical Technologies | Brachytherapy |
ML21230A318 | 30 April 2023 | | DG 8061 (RG 8.39 Rev 2) Release of Patients Administered Radioactive Material | Brachytherapy Eye plaque |
ML24045A274 | 31 March 2023 | | G 2023 Rev 1-24 Final - Use of Radionuclides in the Healing Arts | License Renewal Brachytherapy |
ENS 56378 | 22 February 2023 00:00:00 | Utah Valley Regional Medical Center | Leaking Equipment | |
ENS 56330 | 31 January 2023 21:45:00 | Intermountain Medical Center | Liquid Radioactive Contamination | |
ML23013A329 | 13 January 2023 | | 2023 Qtr 1 Registry of Radioactive Sealed Source and Device Registration Sheets | Tritium Exit Sign Contraband Brachytherapy Moisture Density Gauge Static Eliminator Troxler Moisture Density Gauge Eye plaque Exit Sign Depleted uranium |
ML22342B162 | 8 December 2022 | | SRM-M221206: Meeting with the Advisory Committee on the Medical Uses of Isotopes | |
ML22336A176 | 7 December 2022 | | OEDO-22-00277 Status of Recommendations Office of the Inspector General'S Audit of the Nrc'S Process for Licensing Emerging Medical Technologies (OIG-22-A-07) | |
ML22348A040 | 6 December 2022 | | M221206: Transcript - Meeting with the Advisory Committee on the Medical Uses of Isotopes | Enforcement Discretion Brachytherapy TheraSphere Affidavit |
ML22333B030 | 6 December 2022 | | M221206: Slides - Meeting with the Advisory Committee on the Medical Uses of Isotopes | Brachytherapy TheraSphere |
ML22334A046 | 6 December 2022 | | M221206: Agenda - Meeting with the Advisory Committee on the Medical Uses of Isotopes | |
ML23005A166 | 5 December 2022 | | December 5, 2022, Summary of Meeting Advisory Committee on the Medical Uses of Isotopes (ACMUI) Fall 2022 | |
ML23012A007 | 5 December 2022 | | Transcript of Meeting of the Advisory Committee on Medical Uses of Isotopes (Acmui), December 5, 2022 | Enforcement Discretion Decommissioning Funding Plan Exemption Request Pandemic Brachytherapy TheraSphere |
ML22334A102 | 5 December 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Fall 2022 Meeting Handout | High Radiation Area Enforcement Discretion Decommissioning Funding Plan Brachytherapy TheraSphere |
ML22334A269 | 30 November 2022 | | Advisory Committee on the Medical Uses of Isotope (ACMUI) Fall 2022 Meeting Handout (Revised) | High Radiation Area Enforcement Discretion Decommissioning Funding Plan Brachytherapy TheraSphere |
ML22326A362 | 22 November 2022 | | Draft Regulatory Basis Document for the Rulemaking to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies for ACMUI Review | Enforcement Discretion Decommissioning Funding Plan Exemption Request Brachytherapy TheraSphere |
ML22280A179 | 17 November 2022 | | Rulemaking Attachment - Semiannual Status Report on the Licensing Activities and Regulatory Duties of the U.S. Nuclear Regulatory Commission for the Reporting Period of April 1 - September 30, 2022 | Cyber Security |
ML22314A278 | 9 November 2022 | | Kansas Cross Reference 2018-1 | Brachytherapy |
ML22304A049 | 31 October 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Agenda December 5-6, 2022 | |
ML22223A178 | 11 August 2022 | | VA Amended Regulations 12VAC5-481 | Cyber Security Brachytherapy |
ML22196A076 | 15 July 2022 | | 2nd Qtr Registry of Radioactive Sealed Source and Devices Registration Sheets 071522 | Tritium Exit Sign Contraband Brachytherapy Moisture Density Gauge Static Eliminator Troxler Moisture Density Gauge Eye plaque Exit Sign Depleted uranium |
ML22234A128 | 7 July 2022 | 07001486 | Spectrum Health Hospitals - NRC Form 591M Part 1 & NRC Form 592M, Inspection Report 07001486/2022001 | Brachytherapy Eye plaque |
ML22136A225 | 11 May 2022 | | MD Regulations 26.12.01.01 | Safe Shutdown High Radiation Area Contraband Incorporated by reference Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Earthquake Deep Dose Equivalent Chernobyl Brachytherapy Static Eliminator Stolen Uranium Hexafluoride Tritium Sign Exclusive Use Overexposure Depleted uranium |
ML22136A153 | 10 May 2022 | | Wisconsin Subchapter VI 157 59 to 72 Draft | License Renewal Brachytherapy |
ML22131A271 | 9 May 2022 | | Georgia Regulations Markup 2021 | High Radiation Area Incorporated by reference License Renewal Earthquake Brachytherapy Exclusive Use Overexposure Depleted uranium |
ML22063A454 | 26 April 2022 | | IP 87130 Nuclear Medicine Programs | Reactive Inspection |
ML22102A234 | 21 April 2022 | | Letter to Dr. Carl Marcus from Kevin Williams, Nrc/Nmss/Msst Regarding NRC Staff Evaluation of Medical Specialty Boards | |
ML22094A102 | 5 April 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Revised Handout | Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose |
ML22095A034 | 5 April 2022 | | 2022 Qtr 2 Registry of Radioactive Sealed Source and Devices Registration Sheets | Tritium Exit Sign Contraband Brachytherapy Moisture Density Gauge Static Eliminator Troxler Moisture Density Gauge Eye plaque Exit Sign Depleted uranium |
ML22089A189 | 5 April 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Handout | Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose |